These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34629431)

  • 1. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
    Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
    Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Recurrence-Free Survival After TaTME: A Canadian Institutional Experience.
    Hershorn O; Ghuman A; Karimuddin AA; Raval MJ; Phang PT; Brown CJ
    Dis Colon Rectum; 2024 May; 67(5):664-673. PubMed ID: 38319633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transanal Total Mesorectal Excision: Short-term Outcomes of 1283 Cases from a Nationwide Registry in China.
    Yao H; An Y; Zhang H; Ren M; Chen CC; Xu Q; Wang Q; Zhang Z;
    Dis Colon Rectum; 2021 Feb; 64(2):190-199. PubMed ID: 33395134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Completion Surgery in Unfavorable Rectal Cancer after Transanal Endoscopic Microsurgery: Does It Achieve Satisfactory Sphincter Preservation, Quality of Total Mesorectal Excision Specimen, and Long-term Oncological Outcomes?
    Serra-Aracil X; Galvez SaldaƱa A; Mora-Lopez LL; Montes N; Pallisera-Lloveras A; Serra-Pla S; Pericay C; Navarro-Soto S
    Dis Colon Rectum; 2021 Feb; 64(2):200-208. PubMed ID: 33315715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
    Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
    Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of the Circumferential Resection Margin After Curative Surgery for Rectal Cancer: A Multicenter Propensity Score-Matched Analysis.
    Galvez A; Biondo S; Trenti L; Espin E; Kraft M; Farres R; Codina-Cazador A; Flor B; Garcia-Granero E; Enriquez-Navascues JM; Borda-Arrizabalaga N; Kreisler E
    Dis Colon Rectum; 2023 Jul; 66(7):887-897. PubMed ID: 35348529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anastomosis-Related Complications After Stapled Anastomosis With Reinforced Sutures in Transanal Total Mesorectal Excision for Low Rectal Cancer: A Retrospective Single-Center Study.
    Enomoto H; Ito M; Sasaki T; Nishizawa Y; Tsukada Y; Ikeda K; Hasegawa H
    Dis Colon Rectum; 2022 Feb; 65(2):246-253. PubMed ID: 34657080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and Cost Analysis of Robotic Versus Laparoscopic Abdominoperineal Resection for Rectal Cancer: A Case-Matched Study.
    Gorgun E; Cengiz TB; Ozgur I; Dionigi B; Kalady MF; Steele SR
    Dis Colon Rectum; 2022 Oct; 65(10):1279-1286. PubMed ID: 35195554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological Outcomes and Hospital Costs of the Treatment in Patients With Rectal Cancer: Watch-and-Wait Policy and Standard Surgical Treatment.
    Hupkens BJP; Breukink SO; Stoot JHMB; Toebes RE; van der Sande ME; Melenhorst J; Beets GL; Dirksen CD
    Dis Colon Rectum; 2020 May; 63(5):598-605. PubMed ID: 32032202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
    Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
    Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal Total Mesorectal Excision Versus Anterior Total Mesorectal Excision for Rectal Cancer: A Propensity Score Matched, Population-Based Study in Catalonia, Spain.
    Manchon-Walsh P; de Lacy FB; Pera M; Espin-Basany E; Targarona EM; Biondo S; Aliste Sanchez L; PallarĆØs N; TebĆ© C; Pata F; Lacy AM; Guarga A; BorrĆ s JM
    Dis Colon Rectum; 2022 Feb; 65(2):207-217. PubMed ID: 34636779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
    Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
    Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Positive Circumferential Resection Margin in Rectal Cancer: A Current Audit of the National Cancer Database.
    Simon HL; de Paula TR; Profeta da Luz MM; Kiran RP; Keller DS
    Dis Colon Rectum; 2021 Sep; 64(9):1096-1105. PubMed ID: 33951688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced Lymph Node Staging With Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision for Rectal Cancer: A Retrospective Cohort Study.
    Widmann B; Almarie B; Warschkow R; Beutner U; Weitzendorfer M; Schmid MB; Ukegjini K; Brunner W
    Dis Colon Rectum; 2022 Aug; 65(8):1015-1024. PubMed ID: 34856584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
    Kim HJ; Choi GS; Cho SH; Kang MK; Park JS; Park SY; Kang BW; Kim JG
    Dis Colon Rectum; 2024 Mar; 67(3):359-368. PubMed ID: 37962146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.